Latest Conference Articles

What Is Needed to Improve Pediatric Asthma Controller Therapy Adherence

What Is Needed to Improve Pediatric Asthma Controller Therapy Adherence

February 28th 2021, 10:26pm

American Academy of Allergy, Asthma & Immunology

From better education, to remote monitoring and consistent check-ins, clinicians may need to initiate better adherence in their younger, severely ill patients.

Diverse Eosinophilic Esophagitis Symptoms and Care Teams

Diverse Eosinophilic Esophagitis Symptoms and Care Teams

February 28th 2021, 9:52pm

American Academy of Allergy, Asthma & Immunology

How dupilumab is observed to benefit EoE patients—and who may administer the biologic therapy.

Tezepelumab Benefits Severe, Uncontrolled Asthma in Phase 3 NAVIGATOR Findings

Tezepelumab Benefits Severe, Uncontrolled Asthma in Phase 3 NAVIGATOR Findings

February 28th 2021, 7:57pm

American Academy of Allergy, Asthma & Immunology

An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.

Revised Anaphylaxis Diagnostic Guidelines Seen as an Improvement

Revised Anaphylaxis Diagnostic Guidelines Seen as an Improvement

February 28th 2021, 6:44pm

American Academy of Allergy, Asthma & Immunology

In data presented during AAAAI 21, researchers compared the 2006 and 2016 versions of the diagnostic criteria proposed by the NIAD/FAAN.

Dupilumab for Eosinophilic Esophagitis

Dupilumab for Eosinophilic Esophagitis

February 28th 2021, 6:08pm

American Academy of Allergy, Asthma & Immunology

Perspective on how the interleukin-targeting biologic has unique benefit for the rare, under-resourced disease.

Masks Deemed Safe for Asthma Patients

Masks Deemed Safe for Asthma Patients

February 28th 2021, 5:16pm

American Academy of Allergy, Asthma & Immunology

Oxygen saturation levels similar for both asthma patients and non-asthma patients following mask use.

Sublingual Immunotherapy May Provide Peanut Allergy Desensitization in Toddlers

Sublingual Immunotherapy May Provide Peanut Allergy Desensitization in Toddlers

February 28th 2021, 12:45am

American Academy of Allergy, Asthma & Immunology

Late-breaking data show allegic children as young as 1-4 years old may have sustained benefit from daily peanut protein exposure.

Study: Pediatric Adherence to Drugs Treating Severe Asthma is About 57%

Study: Pediatric Adherence to Drugs Treating Severe Asthma is About 57%

February 28th 2021, 12:45am

American Academy of Allergy, Asthma & Immunology

An interview with a Children's Hospital Colorado investigator on new remote-monitoring research into children's adherence trends.

Early Phase Trial Results Positive for HCQ Against COVID-19

Early Phase Trial Results Positive for HCQ Against COVID-19

February 28th 2021, 12:30am

American Academy of Allergy, Asthma & Immunology

Trials testing hydroxychloroquine against COVID-19 have produced mixed results.

Early Peanut Introduction Decreases Rates of Peanut Allergies

Early Peanut Introduction Decreases Rates of Peanut Allergies

February 28th 2021, 12:30am

American Academy of Allergy, Asthma & Immunology

The adjusted allergy prevalence in recent years was 2.6% in infants who have been introduced to peanuts at 12 months.

x